ADC Therapeutics logo

ADC Therapeutics

ADCT | NYSE
Chart Builder DCF Calculator
$1.25
-$0.09 (-6.72%)
At close: Nov 16, 2026, 4:00 PM ET
$1.28
+$0.03 (+2.40%)
After-hours: Nov 16, 2026, 5:35 PM ET
-6.72%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
47.8
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #334/1021 (Top 33%)

Key Statistics

Market Data

Market Cap $194.26M
1D Range
1.25 1.35
52W Range
0.96 4.88

Valuation (TTM)

PE -2.40
PB -0.78
EV/EBITDA -5.92

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $3.50
Loading financial charts...

Profile

ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its ...

Sector Healthcare
Industry Biotechnology
Employees 191
IPO Date May 18, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 9, 2026
EPS
-$0.16
Beat +24.71%
REV
$21.72M
Beat +16.13%
Next Earnings
Mar 9, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Hold
Price Target
$3.50
Upside
+180.00%
Buy (1)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.